186 related articles for article (PubMed ID: 38018570)
1. Antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis.
Gonçalves MN; Lopes DS; Teixeira SC; Teixeira TL; de Freitas V; Costa TR; Gimenes SNC; de Camargo IM; de Souza G; da Silva MS; Azevedo FVPV; Grego KF; Santos LC; Oliveira VQ; da Silva CV; Rodrigues RS; Yoneyama KAG; Clissa PB; Rodrigues VM
Mem Inst Oswaldo Cruz; 2023; 118():e220225. PubMed ID: 38018570
[TBL] [Abstract][Full Text] [Related]
2. The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection.
Passero LF; Laurenti MD; Tomokane TY; Corbett CE; Toyama MH
Parasitol Res; 2008 Apr; 102(5):1025-33. PubMed ID: 18180953
[TBL] [Abstract][Full Text] [Related]
3. Effect of Isolated Proteins from
Katz S; Barbiéri CL; Soler FPM; Soares AM; Chavantes MC; Zamuner SR
Protein Pept Lett; 2020; 27(8):718-724. PubMed ID: 31994997
[TBL] [Abstract][Full Text] [Related]
4. Isolation and biochemical characterization of a γ-type phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum.
Gimenes SN; Ferreira FB; Silveira AC; Rodrigues RS; Yoneyama KA; Izabel Dos Santos J; Fontes MR; de Campos Brites VL; Santos AL; Borges MH; Lopes DS; Rodrigues VM
Toxicon; 2014 Apr; 81():58-66. PubMed ID: 24513130
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral effects of γCdcPLI, a PLA
Gimenes SNC; Lopes DS; Alves PT; Azevedo FVPV; Vecchi L; Goulart LR; Rodrigues TCS; Santos ALQ; Brites VLC; Teixeira TL; da Silva CV; Dias MH; Teixeira SC; Rodrigues RS; Yoneyama KAG; Oliveira RA; Rodrigues VM
Sci Rep; 2017 Aug; 7(1):7077. PubMed ID: 28765552
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of phospholipase A2 and of peptides from Crotalus durissus terrificus venom against amastigote and promastigote forms of Leishmania (L.) infantum chagasi.
Barros GA; Pereira AV; Barros LC; Lourenço A; Calvi SA; Santos LD; Barraviera B; Ferreira RS
J Venom Anim Toxins Incl Trop Dis; 2015; 21():48. PubMed ID: 26609302
[TBL] [Abstract][Full Text] [Related]
9. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
10. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
Sousa JKT; Antinarelli LMR; Mendonça DVC; Lage DP; Tavares GSV; Dias DS; Ribeiro PAF; Ludolf F; Coelho VTS; Oliveira-da-Silva JA; Perin L; Oliveira BA; Alvarenga DF; Chávez-Fumagalli MA; Brandão GC; Nobre V; Pereira GR; Coimbra ES; Coelho EAF
Parasitol Int; 2019 Dec; 73():101966. PubMed ID: 31362122
[TBL] [Abstract][Full Text] [Related]
11. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
[TBL] [Abstract][Full Text] [Related]
12. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and functional characterization of a new recombinant phospholipase A
Gimenes SNC; Aglas L; Wildner S; Huber S; Silveira ACP; Lopes DS; Rodrigues RS; Goulart LR; Briza P; Ferreira F; de Melo Rodrigues Ávila V; Gadermaier G
Int J Biol Macromol; 2020 Dec; 164():1545-1553. PubMed ID: 32735921
[TBL] [Abstract][Full Text] [Related]
14. BnSP-7 toxin, a basic phospholipase A2 from Bothrops pauloensis snake venom, interferes with proliferation, ultrastructure and infectivity of Leishmania (Leishmania) amazonensis.
Nunes DC; Figueira MM; Lopes DS; De Souza DL; Izidoro LF; Ferro EA; Souza MA; Rodrigues RS; Rodrigues VM; Yoneyama KA
Parasitology; 2013 Jun; 140(7):844-54. PubMed ID: 23442579
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites.
Antinarelli LMR; Meinel RS; Coelho EAF; da Silva AD; Coimbra ES
J Pharm Pharmacol; 2019 Dec; 71(12):1854-1863. PubMed ID: 31595530
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the anti-leishmanial activity of three Crotalus durissus ssp. venoms.
Passero LF; Tomokane TY; Corbett CE; Laurenti MD; Toyama MH
Parasitol Res; 2007 Oct; 101(5):1365-71. PubMed ID: 17659386
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.
Hassan AA; Khalid HE; Abdalla AH; Mukhtar MM; Osman WJ; Efferth T
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364404
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization and assessment of leishmanicidal effects of a new L-amino acid oxidase from Crotalus durissus collilineatus snake venom (CollinLA AO-I).
de Freitas V; Costa TR; Nogueira AR; Polloni L; Alves de Melo Fernandes T; Correia LIV; Borges BC; Teixeira SC; Silva MJB; Amorim FG; Quinton L; Saraiva AL; Espindola FS; Iwai LK; Rodrigues RS; Yoneyama KAG; de Melo Rodrigues Ávila V
Toxicon; 2023 Jul; 230():107156. PubMed ID: 37169266
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Freitas CS; Santiago SS; Lage DP; Antinarelli LMR; Oliveira FM; Vale DL; Martins VT; Magalhaes LND; Bandeira RS; Ramos FF; Pereira IAG; de Jesus MM; Ludolf F; Tavares GSV; Costa AV; Ferreira RS; Coimbra ES; Teixeira RR; Coelho EAF
Exp Parasitol; 2023 Aug; 251():108555. PubMed ID: 37247802
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
